.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Analyze global market entry opportunities
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

QuintilesIMS
Fuji
Healthtrust
Harvard Business School
US Department of Justice
Chubb
Moodys
Mallinckrodt
McKesson
US Army

Generated: June 29, 2017

DrugPatentWatch Database Preview

KANAMYCIN SULFATE Drug Profile

« Back to Dashboard

What is the patent landscape for Kanamycin Sulfate, and what generic Kanamycin Sulfate alternatives are available?

Kanamycin Sulfate is a drug marketed by Abraxis Pharm, Solopak, Fresenius Kabi Usa, Watson Labs, Loch, Intl Medication, Pharmafair, and Warner Chilcott. and is included in twelve NDAs.

The generic ingredient in KANAMYCIN SULFATE is kanamycin sulfate. There are five drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the kanamycin sulfate profile page.

Summary for Tradename: KANAMYCIN SULFATE

Patents:0
Applicants:8
NDAs:12
Suppliers / Packagers: see list1
Bulk Api Vendors: see list83
Clinical Trials: see list643
Patent Applications: see list9,774
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:KANAMYCIN SULFATE at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abraxis Pharm
KANAMYCIN SULFATE
kanamycin sulfate
INJECTABLE;INJECTION062504-003Apr 5, 1984DISCNNoNo► Subscribe► Subscribe
Warner Chilcott
KANAMYCIN SULFATE
kanamycin sulfate
INJECTABLE;INJECTION063092-001Oct 11, 1989DISCNNoNo► Subscribe► Subscribe
Fresenius Kabi Usa
KANAMYCIN SULFATE
kanamycin sulfate
INJECTABLE;INJECTION065111-002Dec 17, 2002RXNoYes► Subscribe► Subscribe
Solopak
KANAMYCIN SULFATE
kanamycin sulfate
INJECTABLE;INJECTION062605-002Feb 26, 1986DISCNNoNo► Subscribe► Subscribe
Loch
KANAMYCIN SULFATE
kanamycin sulfate
INJECTABLE;INJECTION063025-001Jul 31, 1992DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Army
Deloitte
Accenture
Federal Trade Commission
Citi
Healthtrust
Covington
Express Scripts
Argus Health
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot